MIC distribution for (a) amoxicillin/clavulanic acid, ampicillin
Download scientific diagram | MIC distribution for (a) amoxicillin/clavulanic acid, ampicillin, azithromycin and levofloxacin, and (b) cefaclor, cefpodoxime, ceftriaxone, and cefuroxime against H. influenzae. from publication: Results from the Survey of Antibiotic Resistance (SOAR) 2011–13 in Turkey | Objectives: Data are presented from the Survey of Antibiotic Resistance (SOAR) for respiratory tract infection pathogens collected in 2011-13 from Turkey. Methods: MICs were determined using Etest®. Susceptibility was assessed using CLSI, EUCAST and | Turkey, Survey and Surveys and questionnaires | ResearchGate, the professional network for scientists.
MIC distribution for (a) amoxicillin/clavulanic acid, ampicillin
Efficacy and safety of Sultamicillin (Ampicillin/Sulbactan) and Amoxicillin/Clavulanic Acid in the treatment of upper respiratory tract infections in adults - an open-label, multicentric, randomized trial
MIC distributions of b-lactam antibiotics for different SCCmec types.
Intradiscal pharmacokinetics of oral antibiotics to treat Chronic Lower Back Pain
Antibiotics, Free Full-Text
MIC distribution for (a) amoxicillin/clavulanic acid, ampicillin
Frontiers Antimicrobial Susceptibility of Escherichia coli and Salmonella spp. Isolates From Healthy Pigs in Australia: Results of a Pilot National Survey
MIC distribution for (a) amoxicillin/clavulanic acid, azithromycin
Is the standard dose of amoxicillin-clavulanic acid sufficient?, BMC Pharmacology and Toxicology
Frontiers Using bacterial pan-genome-based feature selection approach to improve the prediction of minimum inhibitory concentration (MIC)
Antibiotics, Free Full-Text